Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Aerovate Therapeutics (AVTE) Q2 2024 Earnings
AVTE
13
May
Confirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-0.83
-0.55
-0.28
0
Details
Expected EPS
-0.764567
Actual EPS
-0.83
Surprise EPS
-0.07
Surprise Percent
+8.56%
Description
Aerovate Therapeutics (AVTE) has reported earnings of -0.83 per share for Q2 2024.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login